Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis - Wikidata - awgldk - TriplyDB

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q24609567

about

Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis Trans-translation exposed: understanding the structures and functions of tmRNA-SmpB Learning from the past for TB drug discovery in the future Structural and Kinetic Isotope Effect Studies of Nicotinamidase (Pnc1) from Saccharomyces cerevisiae Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide New insights into TB physiology suggest untapped therapeutic opportunities Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia Induced ectopic expression of HigB toxin in Mycobacterium tuberculosis results in growth inhibition, reduced abundance of a subset of mRNAs and cleavage of tmRNA Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamide TB Mobile: a mobile app for anti-tuberculosis molecules with known targets Mechanisms of Pyrazinamide Action and Resistance New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016).Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.Chemical shift assignments of Ribosomal protein S1 from Mycobacterium tuberculosis.Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.The future of molecular diagnostics for drug-resistant tuberculosis.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria Pyrazinamide and derivatives block ethylene biosynthesis by inhibiting ACC oxidase Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis MSMEG_2731, an uncharacterized nucleic acid binding protein from Mycobacterium smegmatis, physically interacts with RPS1.Latent tuberculosis infection: myths, models, and molecular mechanisms Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study Ribosomal proteins: functions beyond the ribosome Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis Requirements for resuming translation in chimeric transfer-messenger RNAs of Escherichia coli and Mycobacterium tuberculosis Target identification for small bioactive molecules: finding the needle in the haystack.Platforms for antibiotic discovery.Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice.Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity.Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis.Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.Post-translational regulation via Clp protease is critical for survival of Mycobacterium tuberculosis.

P2860

Q27004697-D057CDCA-0F79-477F-9B8B-4307036035EE Q27011264-A265318A-6096-4CC1-AB00-4BED5E45CBDE Q27021295-0839971A-380D-4B3F-816F-65A7E4AC03DC Q27485405-819AD7BE-596A-4761-A3BF-883438184429 Q27676645-19F1EAAF-534A-4B57-8242-FF9B097E5239 Q27696223-6459E9B4-B40D-41F1-A0B0-23098FB2BBA2 Q28388477-7C523E45-5516-461C-B624-7E9C2EC273DD Q28480662-61398C12-98F3-4AB7-ACBE-86FC25973384 Q28486275-3543B75E-5772-4CF6-9E69-7B7FBA7B3E9D Q28487083-71CC35E0-27B4-4657-8163-591AF0CCEC65 Q28539893-80428601-2124-478F-8208-85180AC129D6 Q28709353-26BB111C-B367-4EC1-97B0-9FFE4D7227F5 Q29304444-5A49D404-91C1-49A6-BE61-529F1677690D Q30243915-0DF50089-39B9-4587-9DD1-3EF5DD606305 Q30373724-D6C23531-C943-4772-A462-1B1DE08F0EFA Q30399431-1CF0F8A0-F328-4650-B70E-EE88368F6EB6 Q30408918-A4299D03-6E83-4D2A-A4DB-955B287DA23E Q30419570-6B0BC707-3286-4106-A711-6701E5DABA7C Q30455525-E1DABFA5-9B8C-431E-A9C8-055027657F6A Q33600161-F9715065-CE20-439D-84DF-340016993E50 Q33804763-F835B7CF-1D1E-451D-B986-8E0C16D44D66 Q33810454-766E9EBA-7AD4-4AE0-A858-259C113B599C Q33812455-A5241111-0A74-4E77-9740-AF84267F07E5 Q33912749-AC9C028F-0226-4148-B8D0-B34B653E83C5 Q34113610-4EB88E10-A08F-450C-A3E9-2E1C3D6BC0AF Q34270906-B8180AAE-D330-47EA-BC6C-2DA1796FDD35 Q34297816-818A6231-655D-42E1-9733-7BB84EB3A1F5 Q34420149-1B654145-0409-4F72-9F05-DDF6A49B6033 Q34465473-922C17A9-E53E-4400-9780-DA127C0BA0F7 Q34494098-3EF42C9A-65E9-4B5A-91CC-359842E34193 Q34538623-86ECF3E2-3B54-4F33-B617-AE28F86DCD98 Q34589404-27B80077-892E-472E-BD95-58453167BED1 Q34694926-0CEC6822-5D87-4B2E-B3BC-2BF3FE37057F Q34708437-DB0936A7-164F-4A21-BA8F-84B339A2C0A2 Q34755103-0BE92839-112E-4BE8-A4FB-075C9659463B Q34918855-A4CE81FD-90DF-4939-97B3-1156544FADF5 Q35036087-620430AB-0B99-448F-91BB-DB9768F7C16A Q35076847-1F8BC2E2-DCA4-4E3B-9282-A42FB49F08BA Q35106042-ECFC9144-7752-4509-ACB9-E6752D6977F5 Q35113287-D1303174-76D5-49D5-A992-56516C22D1F0

P2860

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q24609567

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@ast

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@en

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@nl

type

label

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@ast

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@en

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@nl

prefLabel

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@ast

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@en

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@nl

P1433

Q24609567-2EF5E044-26CB-470D-968F-AF43B5673395

P1476

Q24609567-81546B49-0881-44EC-BE69-39CF58763708

P2093

Q24609567-062EAECD-BF11-4857-BBDD-F3F1499F8104

Q24609567-3CB52492-74DD-49EA-BCCC-A8FF70762E2C

Q24609567-5FA5684B-E635-4778-B504-87F8A4D95EA7

Q24609567-71A707C2-A6A9-43CD-8146-6BE6BDECCC4D

Q24609567-7C8586CA-49B7-43CD-97B7-FCB6CF43A252

Q24609567-8E0A3048-6D18-47A2-9323-E978C45A4A62

Q24609567-9A2AF41D-CD38-48E9-B751-EADBDEA47F2D

Q24609567-F59C2A31-ED31-4E11-906B-EF8B997C8320

P2860

Q24609567-17E13808-FF86-4704-8556-00CCDE145561

Q24609567-18C8F093-0918-45E1-BE2F-F73BF2D87898

Q24609567-19F1E9BC-8751-44F6-9F5A-B5C1C02BAA81

Q24609567-1A3EE072-15EB-4251-B773-B9ACBDB38ED6

Q24609567-36BA4972-2293-463E-8BF0-716EB65ACF47

Q24609567-3821D308-B147-4340-B406-95B5F44EF909

Q24609567-3A50E564-3C0B-4DB2-9D58-16066DB30BD3

Q24609567-42D756C7-51ED-4585-A434-E9C09B3D01C2

Q24609567-52415D4D-0066-487D-9E1D-56017B250DFD

Q24609567-615F629A-ACF4-41B1-8557-F7958A1B41B5

P304

Q24609567-E443C286-C140-47B7-9BFD-29740F8DB82B

P31

Q24609567-18F75B34-8B32-4B44-A1D0-5BBBBDEE5031

P3181

Q24609567-3A574820-209D-4425-88D9-BF9E50F52C16

P356

Q24609567-9FFF47AE-9168-4BD3-BC5B-4ECD4B5F90D5

P407

Q24609567-30D50DFA-3C33-4F00-A891-0203F6FE2A6C

P433

Q24609567-AA808FF1-32F3-4AAA-9501-59DF0BBEFA18

P478

Q24609567-894830C0-B2C9-42E9-8984-86A7A975C18A

P50

Q24609567-2E4A78D0-B1AE-469B-8053-29687D65BA4E

P577

Q24609567-A8F79D71-2D7F-4394-AE39-D5CCFF904C84

P5875

Q24609567-B9A6549C-2223-40BF-8FDD-34656AD9B420

P698

Q24609567-48640FA9-499C-4643-93B8-2E893893B5B3

P921

Q24609567-8D7CD663-BA6D-4BA1-AF30-FCE83F303562

Q24609567-D5AFE1FF-1C39-4492-A180-12A6CF3A0272

P932

Q24609567-678CB360-AF9F-4D43-AF47-7ACA40E94A0D

P3181

P356

SCIENCE.1208813

P1433

P1476

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

@en

P2093

Haiming Yuan

http://www.w3.org/2001/XMLSchema#string

Honghai Wang

http://www.w3.org/2001/XMLSchema#string

Jong Seok Lee

http://www.w3.org/2001/XMLSchema#string

Wanliang Shi

http://www.w3.org/2001/XMLSchema#string

Wenhong Zhang

http://www.w3.org/2001/XMLSchema#string

Xin Jiang

http://www.w3.org/2001/XMLSchema#string

Xuelian Zhang

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Trans-translation in Helicobacter pylori: essentiality of ribosome rescue and requirement of protein tagging for stress resistance and competence

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.

Crystal structure of the Xrcc4 DNA repair protein and implications for end joining

Visualizing tmRNA entry into a stalled ribosome

The solution structure of the S1 RNA binding domain: a member of an ancient nucleic acid-binding fold

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

The curious characteristics of pyrazinamide: a review

pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada

P304

1630-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1606190

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1208813

http://www.w3.org/2001/XMLSchema#string

P407

P433

6049

http://www.w3.org/2001/XMLSchema#string

P478

333

http://www.w3.org/2001/XMLSchema#string

P50

Clifton E Barry

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51566039

http://www.w3.org/2001/XMLSchema#string

P698

21835980

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

pyrazinoic acid

P932

3502614

http://www.w3.org/2001/XMLSchema#string